Literature DB >> 17015059

Erythromycin alters the pharmacokinetics of bromocriptine by inhibition of organic anion transporting polypeptide C-mediated uptake.

Wen-Jen Lu, Kelly Huang, Ming-Liang Lai, Jin-Ding Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17015059     DOI： 10.1016/j.clpt.2006.06.003

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  3 in total

1.  OATP1B1 polymorphism as a determinant of erythromycin disposition.

Authors:  C S Lancaster; G H Bruun; C J Peer; T S Mikkelsen; T J Corydon; A A Gibson; S Hu; S J Orwick; R H J Mathijssen; W D Figg; S D Baker; A Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2012-09-19       Impact factor: 6.875

2.  Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3.

Authors:  Regina D Schnegelberger; Brianna Steiert; Philip J Sandoval; Bruno Hagenbuch
Journal:  Front Physiol       Date:  2022-09-08       Impact factor: 4.755

Review 3.  Pharmacogenetics of Parkinson's Disease in Clinical Practice.

Authors:  Jean-Christophe Corvol; Werner Poewe
Journal:  Mov Disord Clin Pract       Date:  2016-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.